Is pravastatin a milestone in the prevention and treatment of preeclampsia?
- PMID: 29570452
- DOI: 10.1515/jpm-2017-0109
Is pravastatin a milestone in the prevention and treatment of preeclampsia?
References
-
- Foidart JM, Schaaps JP, Chantraine F, Munaut C, Lorquet S. Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia – a step forward but not the definitive answer. J Reprod Immunol. 2009;82:106–11.
-
- Ramma W, Ahmed A. Is inflammation the cause of pre-eclampsia? Biochem Soc Trans. 2011;39:1619–27.
-
- Ahmed A. New insights into the etiology of preeclampsia: identification of key elusive factors for the vascular complications. Thromb Res. 2011;127S3:S72–5.
-
- Ramma W, Ahmed A. Therapeutic potential of statins and the induction of heme oxygenase-1 in preeclampsia. J Reprod Immunol. 2014;101–102:153–60.
-
- Van Pampus MG, Aarnoudse JG. Long term outcomes after preeclmapsia. Clin Obstet Gynecol. 2005;48:489–94.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical